Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 64,184 shares at $20.18 ($1.3M) on 2020-12-23, disclosed to the SEC on 2020-12-23.
Open-market sale of $1.3M GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.33 | 18,974 | $386K | 29.7% |
| 2 | $20.33 | 18,974 | $386K | 29.7% |
| 3 | $20.18 | 13,118 | $265K | 20.3% |
| 4 | $20.18 | 13,118 | $265K | 20.3% |
| Total | $20.27 avg | 64,184 | $1.3M | 100% |
| Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |
| GTHX | SELL | 2018-12-04 | $782K | — | Filing → |